Actively Recruiting
Conventional Vs Tailored Limb Lengths in Laparoscopic Roux-en Y Gastric Bypass Surgery
Led by GEM Hospital & Research Center · Updated on 2025-01-03
40
Participants Needed
1
Research Sites
87 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study aims to investigate whether tailoring limb lengths based on the 1/3rd and 2/3rd concept improves clinical outcomes in Laparoscopic Roux-en-Y Gastric Bypass (LRYGB) surgery compared to conventional limb lengths. In this study, two groups were described, first group involves patients who will undergo Lap RYGB with conventional limb lengths of 75cms and 125cms, while the second group is given tailored limb lengths according to the total small bowel length. In the follow up period, Total percentage weight loss, improvement in BMI along with the remission of co-morbidities were also assessed.
CONDITIONS
Official Title
Conventional Vs Tailored Limb Lengths in Laparoscopic Roux-en Y Gastric Bypass Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 65 years
- Body mass index (BMI) of 40 kg/m² or higher, or BMI of 35 kg/m² or higher with at least one obesity-related condition such as type 2 diabetes, hypertension, or obstructive sleep apnea
- ASA physical status classification of 3 or less
- Ability and willingness to provide written informed consent and follow study procedures
- Previous attempts at weight loss through diet, exercise, or medical treatment documented
You will not qualify if you...
- Previous bariatric or major gastrointestinal surgery that could influence the results of LRYGB
- Severe heart or lung diseases posing high surgical risk, such as severe congestive heart failure or severe chronic obstructive pulmonary disease
- Uncontrolled psychiatric disorders or substance abuse, including eating disorders
- Current pregnancy or plans to become pregnant within 12 months after surgery
- Active or recent malignancy requiring treatment within the past 5 years, excluding non-melanoma skin cancer
- Severe liver disease such as cirrhosis or significant liver dysfunction (Child-Pugh B or C)
- Inability or unwillingness to comply with follow-up visits and dietary requirements after surgery
- Chronic use of medications that significantly affect weight or metabolism, including corticosteroids or antipsychotics
- Any other medical or surgical condition that investigators believe makes participation unsuitable
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
GEM Hospital and Research Center
Coimbatore, Tamil Nadu, India, 641045
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here